tlooto
Sign up
SCIESCOPUSQ1

JBI Evidence Synthesis

LIPPINCOTT WILLIAMS & WILKINS, United States

JBI Evidence Synthesis is an academic journal published by LIPPINCOTT WILLIAMS & WILKINS (United States). Identifiers: eISSN 2689-8381. Indexed in SCIE, SCOPUS. Metrics: JIF 4.5, CiteScore 4.2, SJR 1.061, SNIP 1.17. Subject areas: HEALTH CARE SCIENCES & SERVICES. tlooto lists 1,379 papers from this journal.

CiteScore

4.20

Scopus citation metric

SJR

1.061

SCImago rank

SNIP

1.17

Source normalized impact

Percentage rank

-

JIF percentile rank

Journal profile

ISSN
-
eISSN
2689-8381
Abbreviation
JBI EVID SYNTH
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Country
United States

Web of Science categories

No Web of Science category data available.

Scopus ASJC categories

2700 General Medicine2900 General Nursing

Papers in this journal

Recent papers

  1. Effectiveness of support interventions for improving well-being outcomes in parents of preterm infants: an umbrella review protocol

    2026

  2. Physical activity and endogenous pain modulation in older people: a scoping review.

    2026

  3. Mapping application, facilitators, and barriers to virtual nursing for inpatients in acute care hospitals: a scoping review protocol.

    2026

  4. Internationalization of medical education in low and middle-income countries: a scoping review protocol.

    2026

  5. Self-management strategies and assessment tools for people with multimorbidity in the context of health services: a scoping review protocol.

    2026

Most cited papers

  1. Updated methodological guidance for the conduct of scoping reviews

    2020 · 5,766 citations

  2. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool

    2019 · 1,920 citations

  3. Recommendations for the extraction, analysis, and presentation of results in scoping reviews.

    2022 · 1,322 citations

  4. Best practice guidance and reporting items for the development of scoping review protocols

    2022 · 900 citations

  5. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials.

    2023 · 837 citations